Zentalis Pharmaceuticals, INC. (ZNTL) SEC Filings — 2025
15 SEC filings for Zentalis Pharmaceuticals, INC. (ZNTL) in 2025.
Filings
- Zentalis Pharmaceuticals Announces Board and Executive Changes — 8-K · Dec 15, 2025
- Zentalis Narrows Q3 Loss Amidst R&D Cuts, Cash Position Improves — 10-Q · Nov 10, 2025
- Zentalis Pharmaceuticals Announces Board Changes and Filings — 8-K · Aug 26, 2025
- Zentalis Reports No Revenue, Focuses on Clinical Pipeline Advancement — 10-Q · Aug 6, 2025
- Zentalis Pharmaceuticals Files 8-K on Shareholder Vote Matters — 8-K · Jun 18, 2025
- Zentalis Pharmaceuticals Files 8-K — 8-K · Jun 2, 2025
- Zentalis Pharmaceuticals Files Proxy Statement Amendment — DEFA14A · May 23, 2025
- Zentalis Pharmaceuticals Files 8-K — 8-K · May 20, 2025
- Zentalis Pharmaceuticals Files Q1 2025 10-Q — 10-Q · May 14, 2025
- Zentalis Pharma Files 2025 Proxy Statement — DEF 14A · Apr 30, 2025
- Zentalis Pharmaceuticals Files 8-K — 8-K · Apr 28, 2025
- Zentalis Pharmaceuticals Files 2024 10-K — 10-K · Mar 26, 2025
- Zentalis Pharmaceuticals Files 8-K — 8-K · Mar 17, 2025
- Zentalis Pharmaceuticals Files 8-K Report — 8-K · Jan 29, 2025
- Zentalis Sells Subsidiary, Focuses on Oncology Pipeline — 8-K · Jan 28, 2025